Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.

J Cancer · 2019 · PMC6856879 · PMID 31777599

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The validation of PD-L1 expression and inflammatory markers may be significant because they offer the potential for a feasible test that can be used to help evaluate the patient's prognosis.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.